You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

March 18, 2020

Vietnam’s Decree 24 Provides Further Guidance on Alcohol Consumption, Advertising, and Trading

Subscribe to Updates

On February 24, 2020, the government of Vietnam issued Decree No. 24/2020/ND-CP (“Decree 24”) providing detailed guidance on the 2019 Law on Prevention and Control of Harmful Effects of Alcoholic Beverages (the “Law on Alcoholic Beverages”), which took effect on January 1, 2020. Among other things, Decree 24 provides further guidance about the restrictions on consumption, advertising, and trading of alcoholic beverages. Below is a summary of these provisions:

Consumption of alcoholic beverages

Under the Law on Alcoholic Beverages and Decree 24, it is prohibited to consume alcoholic beverages at the locations below:

  1. Healthcare facilities;
  2. Educational institutions during teaching, learning and working hours;
  3. Daycare and recreational centers and facilities for minors (persons under the age of 18);
  4. Detoxification centers, compulsory educational institutions, reform schools, prisons, and other detention facilities;
  5. Social protection centers;
  6. Workplaces of state authorities, political organizations, socio-political organizations, socio-political-professional organizations and public service providers during working hours, except in places that are licensed to sell alcoholic beverages;
  7. Parks, except for restaurants within the park grounds which were licensed to sell alcoholic beverages before the effective date of Decree 24;
  8. Bus stations; and
  9. Cinemas, theatres, cultural establishments, and sports facilities during the time that activities/events are taking place in accordance with the primary uses of those facilities, except in cases of culinary and cultural festivals using alcoholic beverages.

Locations 7-9 were newly added by Decree 24.

Decree 24 additionally restricts the depiction of alcohol consumption in movies, TV shows, or theatrical works. For example, actors cannot be shown consuming alcoholic beverages in the prohibited areas mentioned above, and they cannot praise the success of alcoholic beverage companies. Depictions of alcohol consumption will also be a factor in classifying films by age-appropriate audience.

Advertising and trading of alcoholic beverages

Under the Law on Alcoholic Beverages, advertising of beverages with 15% alcohol content or higher is prohibited, while advertising of beverages with under 15% alcohol content (including beer) is restricted. Decree 24 provides further guidance on the restrictions as follows:

  • Advertising or trading of alcoholic beverages using electronic platforms, including social media, must apply necessary measures to ensure that minors cannot access the advertisements and are not able to purchase the alcoholic beverages.
  • Advertisements of alcoholic beverages must declare, visually or aurally, one of the following warning contents: “Drinking alcoholic beverages can cause traffic accidents,” “Drinking alcoholic beverages can affect fetal health,” or “Persons under the age of 18 are not allowed to drink alcoholic beverages.”
  • For alcoholic beverages with under 5.5% alcohol content, advertising by audiovisual means must not be conducted right before, during, or right after programs for children or during the time from 6 p.m. to 9 p.m. under the Law on Alcoholic Beverages, except in the case of live broadcasts of sporting events from foreign countries. Decree 24 adds to this exception by permitting advertising from event sponsors during the live broadcasts of regional, continental or world sporting events held in Vietnam.
  • Outdoor advertisements of alcoholic beverages with under 5.5% alcohol content must satisfy national technical standards on size and minimum distance from restricted areas (200 meters from general educational and recreational establishments for minors, and 100 meters from vocational training establishments and universities, except for signboards of outlets trading in alcoholic beverages).

It is worth noting that the final two points above do not mean that the advertising of alcoholic beverages with under 5.5% alcohol content is more strictly regulated than for alcoholic beverages with higher alcohol content. Under the Law on Alcoholic Beverages, alcoholic beverages with 5.5% alcohol content or higher are already subject to stricter regulations in these areas.

Implementation

Decree 24 took effect on the date of issuance, February 24, 2020. Any advertising or trading activities conducted or implemented after this date must meet the above conditions. Activities and advertisements violating the above provisions that were conducted or produced before this date may continue to be carried out until June 30, 2020, or until the expiry of the advertising contract; such advertising contracts may not be renewed after expiry.

For more information on Decree 24, please contact us at [email protected].

Related Professionals

Industries

Life Sciences

Technology

Practices

Corporate/M&A

Regulatory Affairs

Location

RELATED INSIGHTS​ 

June 17, 2026
Thailand’s new labeling requirements for medical devices, which include for the first time a unique device identification (UDI) requirement for software as a medical device (SaMD), take effect on June 20, 2026. The Notification of the Ministry of Public Health regarding Criteria, Methods, and Conditions on Labeling and Instructions for Use for Medical Devices 2025, which replaces a similar notification from 2020, was published in the Government Gazette on December 22, 2025. To ensure clarity, modernity, and patient safety, the regulation requires domestic manufacturers and importers to provide labels and instructions for use (IFU) that are clearly legible, complete, and free of false or misleading claims. It also permits IFU to be provided in electronic format, such as via QR codes, websites, or other digital channels—directly relevant to SaMD, where physical labels are impractical and electronic presentation is the natural medium. The notification distinguishes two categories for labeling language. Home-use medical devices (for lay users outside healthcare facilities) must have labels and IFU in Thai. Professional-use medical devices may display labels and documentation in either Thai or English. This distinction is significant for SaMD developers: software intended for clinical professionals may use English-language interfaces and IFU, while consumer-facing health applications must provide Thai-language content. Labeling and UDI Requirements Labels and IFU must include, at a minimum: Product name and intended purpose Quantity or volume Name and address of domestic manufacturer or importer Thai FDA approval number Lot, version, or serial number Manufacturing date and expiry date For SaMD, the version number requirement is particularly relevant. The regulation also mandates display of a UDI code for SaMD in risk category 2 (moderate-risk), category 3 (moderate- to high-risk), and category 4 (high-risk), according to Thailand’s medical device risk classification system (which complies with the ASEAN Medical Device Directive and the EU
Read More
June 15, 2026
The surge in AI development has led to a desperate demand for large, high-quality training data. However, real-world data can be expensive to collect, difficult to access, and often subject to strict privacy and regulatory constraints. Synthetic data, which consists of artificially generated records that replicate the statistical properties of real-world data without reproducing specific individuals’ information, provides an appealing solution by generating artificial datasets at scale without relying on identifiable personal information. It combines speed, cost efficiency, and regulatory compliance, making it a sensible alternative for organizations seeking to reduce risks while maintaining data utility. When properly anonymized, synthetic datasets may fall outside the scope of laws such as the EU’s General Data Protection Regulation (GDPR) or Thailand’s Personal Data Protection Act (PDPA), reducing compliance burdens while still supporting high-quality model training. However, relying on synthetic data without rigorous legal due diligence could be a strategic mistake. It replaces one set of known risks (scraping, direct privacy liability) with a new set of complex liabilities. The narrative that synthetic data is a “silver bullet” for privacy and IP compliance is dangerous and could be misleading. While synthetic data addresses data scarcity, it also introduces new legal uncertainties. Legal counsel should anticipate downstream risks arising from compromised data sources. Models trained on unlawfully obtained data may need to be decommissioned, even if their outputs appear lawful. What is synthetic data? Synthetic data refers to artificially generated information created using AI techniques such as deep learning and generative models. Instead of copying real records, it reproduces the statistical patterns and relationships found in the original dataset. Synthetic data generally falls into three categories: Fully synthetic data – Entirely new data points generated from learned patterns. The model studies the structure of the original data and produces records that resemble real-world
Read More
June 11, 2026
Thailand’s Electronic Transactions Development Agency (ETDA) has released a revised draft Electronic Transactions Act (ETA) for public hearing from May 12, 2026, to June 15, 2026. This is not merely an amendment to certain provisions of the current ETA, but a comprehensive redrafting of the entire act. The revised draft ETA introduces several significant changes from the current framework, with practical implications for businesses operating in Thailand. Unified Coverage of Public and Private Sectors The current law segregates government transactions into a separate chapter with distinct rules. The draft ETA eliminates this division, defining “transaction” to encompass civil and commercial juristic acts as well as administrative procedures, administrative contracts, and other acts of government agencies. Enhanced E-Signature Definition The definition of “electronic signature” is broadened to expressly include biometric data and refocused on identifying the signatory and demonstrating intent regarding the content of the electronic data. Shift in Burden of Proof When a party challenges the reliability of electronic data created using a “trusted electronic method” or a method prescribed by the ETDA, the burden of proof and the cost of proving unreliability shifts to the challenger. Introduction of New Digital Method Concepts The draft ETA introduces several new digital method concepts that are not currently recognized under the existing ETA framework. These include: Electronic timestamping (e-timestamp) Electronic registered delivery Electronic company seals Electronic stamp duty compliance Electronic identity authentication and verification Electronic transferable records (electronic bills of lading, promissory notes, and similar negotiable instruments) Recognition of Automated Systems and Electronic Contracting The draft ETA expressly recognizes the legal validity and enforceability of contracts formed through automated systems, including contracts concluded entirely between automated systems or between an automated system and a person. A party may not deny the binding effect of such contracts solely because no human review
Read More
June 5, 2026
On May 25, 2026, Vietnam’s Ministry of Health issued Circular No. 16/2026/TT-BYT governing free-of-charge medicine support programs for medical establishments (Circular 16). Circular 16 will take effect on July 10, 2026, replacing Circular No. 31/2018/TT-BYT, which currently regulates the same subject matter. Circular 16 introduces several significant changes compared to the existing legal framework. Removal of Prior Approval Requirement Under the current regulations, free-of-charge medicine support programs are divided into two categories: (1) entirely free-of-charge provision of medicines for all types of drugs and (2) partially free-of-charge provision applicable only to brand-name drugs under patent protection or drugs whose generic products with identical active ingredients and dosage forms are available in Vietnam. Under the current regulations, partially free-of-charge programs are subject to mandatory registration with the competent authority, while entirely free-of-charge programs could be implemented without prior approval. A key reform under Circular 16 is that it stipulates only entirely free-of-charge medicine support programs applicable to all types of medicines, thereby eliminating the partially free-of-charge category. In addition, free-of-charge medicine support programs may be carried out solely based on a written agreement between the pharmaceutical company and the medical establishment, without any requirement for prior approval from competent authorities prior to implementation. Written Agreement Requirements Circular 16 requires the pharmaceutical company and medical establishment to enter into a written agreement in accordance with a prescribed template. This agreement must include the following compulsory information: Information on the supported medicines Form of support (entirely free-of-charge provision to patients) Quantity of medicines provided Target patient groups and applicable indications Duration of the program Rights and obligations of each party Transitional provisions on the protection of patients’ rights upon completion of the program The agreement may contain other contents as agreed by the parties, provided that these do not contradict applicable laws.
Read More